Montelukast Sodium Tablet, Chewable
Product Images NDC 13668-080

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 13668-080). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

13ed8fe9 B0a7 4906 81a0 C2e253a3f180 01

A line graph depicting change in height (cm) over weeks on treatment comparing Montelukast Sodium 5 mg, Beclomethasone 336 mcg, and placebo groups. The x-axis represents weeks on treatment from -19 to 56, and the y-axis shows change in height from -3 to 7 cm, illustrating growth trends during the study period.*

FDA Label Image

13ed8fe9 B0a7 4906 81a0 C2e253a3f180 02

Chemical structure diagram of montelukast sodium, showing molecular arrangement including aromatic rings, a chlorine atom, sulfur, a cyclopropyl group, and a carboxylate sodium salt moiety.*

FDA Label Image

13ed8fe9 B0a7 4906 81a0 C2e253a3f180 03

A line graph depicting the mean percent change from baseline over weeks in treatment and during a washout period. The x-axis shows weeks in treatment from 0 to 12, followed by a washout period ending at week 15. The y-axis shows mean percent change from baseline from 0 to 15. Two datasets are shown: one for Placebo with lower percent change, represented by squares, and another for Montelukast Sodium with higher percent change that peaks around week 12 and declines during the washout, represented by circles.*

FDA Label Image

13ed8fe9 B0a7 4906 81a0 C2e253a3f180 04

FDA Label Image

13ed8fe9 B0a7 4906 81a0 C2e253a3f180 06

Montelukast Sodium Chewable Tablets, USP 4 mg, label for a 30-tablet bottle. The label includes storage instructions, manufacturer information (Torrent Pharmaceuticals Ltd, India), and a warning for phenylketonurics about phenylalanine content. The product is indicated for pediatric patients aged 2-5 years and is marked Rx only.*

FDA Label Image

13ed8fe9 B0a7 4906 81a0 C2e253a3f180 07

Label for Montelukast Sodium Chewable Tablets, USP 4 mg by Torrent Pharmaceuticals Limited. The label indicates 30 tablets with NDC 13668-079-30. It includes dosing guidance for pediatric patients aged 2-5 years, storage instructions, and warnings for phenylketonurics. The label also states the product is Rx only and provides manufacturer information for Torrent Pharmaceuticals Ltd, India.*

FDA Label Image

13ed8fe9 B0a7 4906 81a0 C2e253a3f180 08

Label for Montelukast Sodium Chewable Tablets, USP 5 mg, containing 30 tablets. Manufactured by Torrent Pharmaceuticals Limited, this label includes storage instructions, dosage notice, and a warning for phenylketonurics. The National Drug Code (NDC) is 13668-080-30. The label features the Torrent Pharma logo and indicates prescription-only status.*

FDA Label Image

13ed8fe9 B0a7 4906 81a0 C2e253a3f180 09

Label for Montelukast Sodium Chewable Tablets, USP 5 mg, containing 30 tablets. The label indicates it is for pediatric patients aged 6-14 years and includes storage instructions and warnings. Manufactured by Torrent Pharmaceuticals Limited and distributed by Torrent Pharma Inc.*

FDA Label Image

13ed8fe9 B0a7 4906 81a0 C2e253a3f180 10

Montelukast Sodium Tablets, USP 10 mg label for a bottle of 30 tablets by Torrent Pharmaceuticals Limited. The label includes storage instructions, dosage guidance, manufacturer details, and a barcode. The tablet strength is prominently displayed in green and white on the front.*

FDA Label Image

13ed8fe9 B0a7 4906 81a0 C2e253a3f180 11

Label for Montelukast Sodium Tablets, USP 10 mg by Torrent Pharmaceuticals Limited. The package contains 30 tablets. The label includes storage instructions, dosage information, manufacturer details, and a barcode. It specifies the drug as Rx only and for adults 15 years and older.*

FDA Label Image

13ed8fe9 B0a7 4906 81a0 C2e253a3f180 12

Montelukast Sodium Oral Granules 4 mg carton label from Torrent Pharmaceuticals Limited. The label states it is for oral granules, with 4 mg strength, intended for pediatric use ages 6 months to 6 years. It includes opening instructions with a tear or cut line, NDC 13668-531-11, and notes the granules contain 4.16 mg Montelukast sodium USP equivalent to 4 mg Montelukast.*

FDA Label Image

13ed8fe9 B0a7 4906 81a0 C2e253a3f180 13

Montelukast Sodium Oral Granules USP 4 mg packaging label by Torrent Pharmaceuticals Limited. The label indicates 30 packets per container, for pediatric patients aged 6 months to 5 years. The front and side panels include dosage instructions, storage information, and barcode with NDC 13668-531-94. The label states this is an Rx-only product.*

FDA Label Image

Ifu Logo

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.